CYTK

Cytokinetics Inc$80.36 2.74%
Health CareUSCUSIP 23282W605· EOD Jul 16, 2026◍ Confluence graph
Tracked 13F Holders
327
+13 QoQ
13F Value (tracked)
$7.5B
Insider Net · 180d
-$27.9M
0↑ 8↓
Recent Filings
15
Smart-money sentimentMixed
BearishBullish
13F funds (latest Q)37 adding · 27 trimming
Insider net (180d)-$27.9M

Price & smart-money activity

$80.36 2.74%5Y +197.6%
$20.90$42.58$64.25$85.93$107.612021202220232024202520263927454028373857271044941473939484243442458539960816269655880776168721076510094192108100106
Hover for who · click for detailEnd-of-day closing prices52w $33.23 – $87.26
Build

Ask your agent what changed in CYTK

This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/stocks/CYTK/capital-change-brief"
Ask your agent
Use Arkolith's capital_change_brief for CYTK.
Tell me what changed, whether insider activity
corroborates it, and cite the SEC evidence.

Top institutional holders

327 tracked 13F filers
1 source-reported value row is withheld because the reported units do not agree with same-security peers. Share counts remain visible and unchanged.
#FundPosition valueSharesLast moveAs ofHistory
1T. Rowe Price Investment Management, Inc.
Withheld
17.5M
−1.1%
Reduced · −193K sh
Q1 2026
2BlackRock, Inc.
$1.1B
16.5M
+0.9%
Added · +153K sh
Q1 2026
3FMR LLC
$706.8M
10.7M
−16%
Reduced · −2.1M sh
Q1 2026
4VANGUARD PORTFOLIO MANAGEMENT LLC
$385.2M
5.8M
New
+5.8M sh
Q1 2026
5STATE STREET CORP
$378.7M
5.7M
−1.4%
Reduced · −80K sh
Q1 2026
6VANGUARD CAPITAL MANAGEMENT LLC
$361.8M
5.5M
New
+5.5M sh
Q1 2026
7Avoro Capital Advisors LLC
$219.7M
3.3M
New
+3.3M sh
Q1 2026
8GEODE CAPITAL MANAGEMENT, LLC
$212.0M
3.2M
+5.2%
Added · +159K sh
Q1 2026
9BANK OF AMERICA CORP /DE/
$206.0M
3.1M
+6.3%
Added · +184K sh
Q1 2026
10RTW INVESTMENTS, LP
$179.4M
2.7M
Held
Q1 2026
11GOLDMAN SACHS GROUP INC
$145.4M
2.2M
−7.0%
Reduced · −166K sh
Q1 2026
12UBS Group AG
$136.9M
2.1M
+84%
Added · +946K sh
Q1 2026
13Polar Capital Holdings Plc
$109.5M
1.7M
−31%
Reduced · −761K sh
Q1 2026
14Integral Health Asset Management, LLC
$105.5M
1.6M
+14%
Added · +200K sh
Q1 2026
15PRICE T ROWE ASSOCIATES INC /MD/
$104.4M
1.6M
−18%
Reduced · −346K sh
Q1 2026
16MORGAN STANLEY
$99.2M
1.5M
+19%
Added · +240K sh
Q1 2026
17Paradigm Biocapital Advisors LP
$97.6M
1.5M
New
+1.5M sh
Q1 2026
18NORTHERN TRUST CORP
$95.0M
1.4M
+4.4%
Added · +61K sh
Q1 2026
19CHARLES SCHWAB INVESTMENT MANAGEMENT INC
$92.1M
1.4M
+1.0%
Added · +14K sh
Q1 2026
20Deep Track Capital, LP
$90.6M
1.4M
−59%
Reduced · −2.0M sh
Q1 2026
21Frazier Life Sciences Management, L.P.
$76.4M
1.2M
+24%
Added · +225K sh
Q1 2026
22CITADEL ADVISORS LLC
$72.5M
1.1M
−5.4%
Reduced · −63K sh
Q1 2026
23PRINCIPAL FINANCIAL GROUP INC
$72.1M
1.1M
+12%
Added · +117K sh
Q1 2026
24WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
$71.7M
1.1M
New
+1.1M sh
Q1 2026
25Bank of New York Mellon Corp
$66.3M
1.0M
+18%
Added · +152K sh
Q1 2026

Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

Fund activity: latest quarter

Opened (NEW)
11
funds
Added
26
funds
Reduced
27
funds
Exited
0
funds

Insider activity (Form 4)

Full insider page →
Buys · 180d
$0
0 insiders
Sells · 180d
$27.9M
8 insiders
Net
-$27.9M
50 P/S txns
Signal
Net Selling
open-market
DateInsiderRoleActionSharesValue
Jul 15, 2026HENDERSON JOHN TDirectorGrant (A)272$22K
Jul 15, 2026Kaye Edward M. MDDirectorGrant (A)151$12K
Jul 15, 2026Wysenski NancyDirectorGrant (A)75$6K
Jul 15, 2026Daly James MDirectorGrant (A)151$12K
Jul 15, 2026Harrington Robert ArthurDirectorGrant (A)151$12K
Jul 15, 2026WIERENGA WENDELLDirectorGrant (A)75$6K
Jul 13, 2026Blum Robert IPresident & CEO, DirectorOption exercise (M)7K$0
Jul 13, 2026Blum Robert IPresident & CEO, DirectorSell (S)7K$614K
Jul 13, 2026Blum Robert IPresident & CEO, DirectorOption exercise (M)7K$79K
Jul 13, 2026Blum Robert IPresident & CEO, DirectorSell (S)10$820
Jul 7, 2026Malik Fady IbrahamEVP Research & DevelopmentOption exercise (M)4K$27K
Jul 7, 2026Malik Fady IbrahamEVP Research & DevelopmentSell (S)4K$303K

Institutional ownership over time

327 funds+102 since Q3 2024
0164327Q3 2024Q1 2025Q3 2025Q1 2026
funds holding aggregate valuelatest $7.4B · 1 values withheld

Funds that own CYTK also own

CompanyCo-held byCombined value
NVIDIA CORPNVDA139 funds$85.0B
MICROSOFT CORPMSFT139 funds$58.9B
ALPHABET INC-CL AGOOGL139 funds$37.9B
AMAZON.COM INCAMZN138 funds$44.3B
ELI LILLY & COLLY138 funds$16.1B
BOSTON SCIENTIFIC CORPBSX138 funds$3.4B
BROADCOM INCAVGO137 funds$33.0B
META PLATFORMS INC-CLASS AMETA137 funds$26.6B
UNITEDHEALTH GROUP INCUNH134 funds$5.4B
APPLE INCAAPL133 funds$66.2B
MICRON TECHNOLOGY INCMU133 funds$11.8B
VISA INC-CLASS A SHARESV133 funds$11.7B

Ranked by how many of CYTK's institutional holders also hold each name, a cross-fund conviction signal. Via the MCP server (ticker.co_held).

Recent filings

15 shown

Browse more

13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for CYTK. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes. Every panel above is one call to the Arkolith API & MCP server.